Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium
07.08.2025 - 18:05:28
Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysisaXess is a restorative arteriovenous dialysis conduit which allows vascular access for hemodialysis through the creation of a new, long-term living vesselView original content:https://www.prnewswire.co.uk/news-releases/xeltis-announces-latest-results-from-axess-trials-to-be-presented-at-46th-annual-charing-cross-symposium-302118528.html
